About
Drugs Made In America Acquisition Corp. Units (NASDAQ:DMAAU) — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 24 2025
Drugs Made in America Acquisition Corp. Announces Advisory Team
Feb 20 2025
Drugs Made In America Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing February 25, 2025
Feb 18 2025
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option
Jan 29 2025
Drugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
Jan 27 2025
Drugs Made In America Acquisition Corp. Announces Pricing of $200,000,000 Initial Public Offering
Financials
Revenue
$0
Market Cap
$308.64 M
Google Übersetzer